Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

Tanshinone IIA helps protect skin tissue from low oxygen damage by boosting certain cell markers.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Taohong Siwu Decoction may help treat deep vein thrombosis by reducing inflammation.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

Long-term use of calcineurin inhibitors in transplant patients can cause hormone issues that can be managed with proper care.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

Dicentrine reduced heart disease risk factors in rats, T-588 protected mice brains without side effects, Provir blocked herpes virus and lessened mouse symptoms, and LY191704 could treat hair loss and prostate issues.

These new skin treatments are safer and more effective with minimal side effects.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

M50054 may help treat hepatitis and hair loss from chemotherapy.

RTA 408 cream protects mice from radiation skin damage.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Nano-PROTACs could improve drug targeting and delivery by using nanotechnology.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

New itaconate prodrugs improve its absorption and effectiveness for treating inflammation.

Co-trimoxazole may help treat autoimmune diseases.

JAK inhibitors like tofacitinib may effectively treat alopecia in children without major side effects.

Antihepcidin antibodies may treat inflammation-induced anemia by improving iron metabolism.